Data as of Jan 29
| +0.02 / +0.24%|
The 4 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 12.50, with a high estimate of 20.00 and a low estimate of 11.00. The median estimate represents a +46.89% increase from the last price of 8.51.
The current consensus among 4 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.